LYEL - Lyell Immunopharma announces up to $100 million equity private placement
2025-07-25 08:35:18 ET
More on Lyell Immunopharma
- Lyell: 'Hold' Rating Based On Phase 3 LYL314 LBCL Treatment Program Advancement
- Lyell Immunopharma strengthens clinical and commercial capabilities with executive appointments
- Seeking Alpha’s Quant Rating on Lyell Immunopharma
- Historical earnings data for Lyell Immunopharma
- Financial information for Lyell Immunopharma